Gene Therapy Market PPT: Overview, Dynamics, Trends, Segmentation, Application and Forecast to 2032

1. Global Gene Therapy
Market Research and
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved

2. About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on management
strategy and market research worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their most critical challenges, and
transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods
are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.

3. Report Highlight
and Description
According to the latest report by IMARC Group, titled "Gene Therapy Market:
Global Industry Trends, Share, Size, Growth, Opportunity and Forecast
2024-2032," the global gene therapy market size reached US$ 5.1 Billion in
2023.
Gene therapy refers to an advanced medical technique that involves modifying
the genes inside the cells of the patient's body to treat or prevent the
progression of the disease. It works by replacing a defective gene with a new,
normal and healthy gene in a cell to cure the disease or improve the body's
ability to fight it.
It is also used to treat numerous chronic and genetic disorders in human
beings that have no other cures. Nowadays, manufacturers are offering a wide
variety of gene therapy products, including plasmid deoxyribonucleic acid
(DNA), human gene-editing technology, patient-derived cellular gene therapy,
viral vectors, and bacterial vectors, which is currently escalating their demand
across the globe.
Request for a PDF sample of this report: https://www.imarcgroup.com/gene-
therapy-market/requestsample

4. Report Description
Global Gene Therapy Market Trends:
The rising prevalence of genetic and acquired diseases, such as cancer, diabetes, cardiovascular diseases
(CVDs), cystic fibrosis, and acquired immunodeficiency syndrome (AIDS), represents the primary factor driving
the market growth. Besides this, the expanding geriatric population that is more susceptible to developing such
chronic health conditions has catalyzed the product demand. Additionally, there has been a significant increase in
government support and funding for gene therapy research. Along with this, the growing awareness regarding the
benefits of gene therapy and easy accessibility to healthcare facilities have accelerated the product adoption
rate. Furthermore, several key players are engaging in research and development (R&D) activities and making
heavy investments toward product innovations to gain a competitive edge.
Moreover, the introduction of new gene therapy that provides a safer and non-addictive alternative to opioids in
treating various chronic pain conditions, such as lower back pain and rare neuropathic pain disorders, has
propelled the market growth. Other factors, including the increasing approvals of gene therapy products,
favorable reimbursement policies, improving healthcare infrastructure, rising consumer healthcare expenditure,
and technological advancements, are also providing a positive impact on the market growth.
Looking forward, IMARC Group expects the market to reach US$ 16.8 Billion by 2032, growing at a CAGR of
13.9% during 2024-2032.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/gene-therapy-market

5. Report
Segmentation
Breakup by Gene Type:
• Antigen
• Cytokine
• Tumor Suppressor
• Suicide Gene
• Deficiency
• Growth Factors
• Receptors
• Others
Breakup by Vector Type:
• Viral Vector
o Adenoviruses
o Lentiviruses
o Retroviruses
o Adeno-Associated Virus

6. Report
Segmentation
o Herpes Simplex Virus
o Poxvirus
o Vaccinia Virus
o Others
• Non-Viral Techniques
o Naked and Plasmid Vectors
o Gene Gun
o Electroporation
o Lipofection
o Others
Breakup by Delivery Method:
• In-Vivo Gene Therapy
• Ex-Vivo Gene Therapy

7. Report
Segmentation
Breakup by Application:
• Oncological Disorders
• Rare Diseases
• Cardiovascular Diseases
• Neurological Disorders
• Infectious Disease
• Others
Breakup by Region:
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

8. Competitive
Landscape with
Key Players
• Abeona Therapeutics Inc.
• Adaptimmune Therapeutics plc
• Adverum Biotechnologies Inc.
• Amgen Inc.
• Astellas Pharma Inc.
• Biogen Inc.
• Bluebird Bio Inc.
• Mustang Bio Inc. (Fortress Biotech Inc.)
• Novartis AG
• Orchard Therapeutics plc
• UniQure N.V.
• Voyager Therapeutics Inc.

9. Key Questions
Answered in
the Report
How big is the global gene therapy market?
What is the expected growth rate of the global gene therapy
market during 2024-2032?
What are the key factors driving the global gene therapy
market?
What has been the impact of COVID-19 on the global gene
therapy market?
What is the breakup of the global gene therapy market based
on the vector type?
What is the breakup of the global gene therapy market based
on the application?
What are the key regions in the global gene therapy market?
Who are the key players/companies in the global gene therapy
market?

10. Table of
Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Gene Therapy Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Gene Type
6.1 Antigen
6.1.1 Mark et Trends
6.1.2 Mark et Forecast
6.2 Cytokine
6.2.1 Mark et Trends
6.2.2 Mark et Forecast
6.3 Tumor Suppressor
6.3.1 Mark et Trends
6.3.2 Mark et Forecast

11. Table of
Contents
6.4 Suicide Gene
6.4.1 Mark et Trends
6.4.2 Mark et Forecast
6.5 Deficiency
6.5.1 Mark et Trends
6.5.2 Mark et Forecast
6.6 Growth Factors
6.6.1 Market Trends
6.6.2 Mark et Forecast
6.7 Receptors
6.7.1 Mark et Trends
6.7.2 Mark et Forecast
6.8 Others
6.8.1 Mark et Trends
6.8.2 Mark et Forecast
7 Market Breakup by Vector Type
7.1 Viral Vector
7.1.1 Mark et Trends
7.1.2 Key Segments
7.1.2.1 Adenoviruses
7.1.2.2 Lentiviruses
7.1.2.3 Retroviruses
7.1.2.4 Adeno -Associated Virus
7.1.2.5 Herpes Simplex Virus
7.1.2.6 Poxvirus
7.1.2.7 Vaccinia Virus
7.1.2.8 Others
7.1.3 Mark et Forecast
7.2 Non-Viral Techniques
7.2.1 Mark et Trends
For more information, visit :
https://www.imarcgroup.com/gene -therapy-market/toc

12. Disclaimer
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the
name of International Market Analysis Research and Consulting (IMARC). No part of this
publication may be reproduced, repackaged, redistributed or resold in whole or in any part.
The publication may also not be used in any form or by and means graphic electronic or
mechanical, including photocopying, recording, taping or by information storage or retrieval,
or by any other form, without the express consent of International Market Analysis Research
and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and
opinion have been based on information and sources believed to be accurate and reliable at
the time of publishing. International Market Analysis Research and Consulting makes no
representation of warranty of any kind as to the accuracy or completeness of any Information
provided. IMARC accepts no liability whatsoever for any loss or damage resulting from
opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of
International Market Analysis Research and Consulting. All other trademarks used in this
publication are registered trademarks of their respective companies.

13. Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com